Determination of Methylmalonic Acid in Serum, Plasma and Urine by LCMS-8030 using RECIPE ClinMass Complete Kit MS5000

Importance of the Topic

The quantification of methylmalonic acid (MMA) is essential in clinical diagnostics as a specific marker for methylmalonic acidemias and vitamin B12 deficiency. Accurate MMA measurement supports early detection of inborn errors of metabolism and monitoring of B12 status, directly impacting patient management and therapeutic decisions.

Objectives and Study Overview

This study aimed to develop and validate a rapid, sensitive, and minimally invasive LC-MS/MS method for measuring MMA in serum, plasma, and urine. Utilizing Shimadzu’s LCMS-8030 system paired with the ClinMass® Complete Kit MS5000, the approach focuses on high throughput, minimal sample preparation, and robust quantitation across clinically relevant concentration ranges.

Methodology and Instrumentation

Sample Preparation:

• Mix 100 µL biological sample with 400 µL precipitant solution containing deuterated internal standard.
• Centrifuge and inject 10 µL supernatant directly without further extraction.

Chromatography and Mass Spectrometry:

• UHPLC: Nexera system at 30 °C, flow 0.8 mL/min, gradient from 20% to 90% organic phase to enable elution in under two minutes.
• Mass Spectrometer: LCMS-8030 triple quadrupole with electrospray ionization in negative mode.
• MRM transitions: MMA 117.1→73.2 and 117.1→55.2; D3-MMA 120.1→75.9. Source parameters optimized for rapid desolvation and ion transmission.

Main Results and Discussion

The method achieved baseline separation of MMA and internal standard in less than two minutes with sharp peak shapes. Calibration demonstrated excellent linearity (R² = 0.9958) over 26.1–177 µg/L. Duplicate analysis of two patient samples yielded concentrations of 26.7 µg/L and 65.7 µg/L, with relative standard deviations below 5%, confirming precision and reproducibility.

Benefits and Practical Applications

This workflow offers significant advantages for clinical laboratories:

• Minimal sample volume (10 µL injection) and simple protein precipitation accelerate throughput.
• Fast chromatography reduces run time, enabling high sample throughput.
• High sensitivity and linearity across relevant clinical ranges ensure reliable decision support.

Future Trends and Applications

Emerging directions include integration of high-resolution mass spectrometry for multiplexed metabolite panels, further automation of sample prep to reduce hands-on time, and implementation in point-of-care platforms. Advances in microflow LC and novel stationary phases may also enhance sensitivity and decrease solvent consumption.

Conclusion

The combination of Shimadzu’s LCMS-8030 system with the ClinMass® Complete Kit delivers a streamlined, robust, and high-throughput assay for MMA measurement in biological fluids. Its simplicity, precision, and clinical relevance make it well suited for diagnostic and monitoring applications in clinical laboratories.

References

Grüning A., Bonnington L. Determination of Methylmalonic Acid in Serum, Plasma and Urine by LCMS-8030 using RECIPE ClinMass® Complete Kit MS5000. Shimadzu Europe GmbH & RECIPE Chemicals + Instruments GmbH, 2013.